To assess the subtypes of HR+/HER2-0 and HR+/HER2-low breast cancer, 50 genes across diverse breast cancer cell lines were examined using PAM50 typing (GSE212143) derived from transcriptome data in the GEO database30. This evidence concerns the gene ERBB2 and breast carcinoma.